Rabies Free Pakistan (RFP), a joint initiative of Getz Pharma and Indus Hospital & Health Network, held a webinar to commemorate World Rabies Day 2021. The webinar was attended by Managing Director & CEO at Getz Pharma, Khalid Mahmood, Special Assistant to the Prime Minister on National Health Services, Dr. Faisal Sultan, Executive Director, NIH, Maj Gen Aamir Ikram, DG Health, Rana Muhammad Safdar, Program Director RFP, Dr. Naseem Salahuddin, Chief Biological Production, NIH, Dr. Ghazala Parveen and office bearers of local government.
Getz Pharma, Pakistan's leading pharmaceutical company, and the Institute of Business Administration (IBA), Karachi, the country's prestigious higher education institution, have partnered to establish Getz Pharma Endowment Fund. The initiative aims to advance the Institute's financial assistance program for its deserving students selected from all over the country. Through this partnership, Getz Pharma will financially support students chosen from the National Talent Hunt Program (NTHP) at IBA Karachi.
Wanting to create a truly green facility, Getz Pharma designed and built its new manufacturing facility, Astola, as per the comprehensive guidelines laid out by U.S. Green Building Council (USGBC) to steer the country towards an environmentally sustainable future. Located in the heart of Karachi’s Korangi Industrial Area, the Astola plant is equipped with state-of-the-art green building features, designed to efficiently reduce carbon emissions, water usage, and energy consumption.
Getz Pharma conducted the SAFE-PAK study, Pakistan's first randomized controlled clinical trial to test the safety and efficacy of Empagliflozin - a medicine used to treat type 2 diabetes. Getz Pharma unveiled the promising results of the SAFE-PAK study with the leading health care fraternity at the 7th Mid-Summer Endocrine Updates, hosted by the Pakistan Endocrine Society.
You are about to be redirected to an online retailer’s website. Getz Pharma is not liable for any data exchange on the new website
You will be redirected in 3secs
Disclaimer: "This message (including attachment) is intended solely for the use of the individual or entity whom it is addressed and may contain information that is confidential or privileged. If you are not the intended recipient of this message, you are hereby notified that any use, dissemination, distribution or reproduction of this message is prohibited and that, you must not take any action in reliance on it. E-mail transmission cannot be guaranteed to be secure or error-free as information could be intercepted, corrupted, lost, destroyed, arrived incomplete or contain viruses; therefore Getz Pharma (Private) Limited cannot accept legal responsibility for the contents of this message. If you have received this communication in error, please notify the sender or Getz Pharma (Private) Limited at [email protected] immediately and destroy the original message."
Close
